Provider
QP96-21 Processing Change for HCPCS Code A9279
Program effective Date: Dec 08, 2021
Search Results
Displaying 2111 - 2120 of 3661 results
Provider
QP97-21 MHCP Pharmacy Benefit Exclusion for Asparlas™, Khapzory™, Nulojix®, Oncaspar® and Susvimo™
Program effective Date: Dec 08, 2021
Provider
Gonadotropin Hormones - Commercial
Prior Authorization, Quantity Limit
Program effective Date: Nov 01, 2024
Provider
P64-21 Update to Reimbursement Policy Durable Medical Equipment (DME) - 002 Oxygen Aiding Equipment
Program effective Date: Nov 01, 2021
Provider
P65-21 Change in Claim Submission for Medicare Members for COVID-19 Vaccines and Monoclonal Antibody Treatment
Program effective Date: Nov 01, 2021
Provider
P66-21 New Medical, Medical Drug and Behavioral Health Policy Management Updates—Effective January 3, 2022
Program effective Date: Nov 01, 2021
Provider
P67-21 Medical Drug Policy Update – Infliximab Preferred Product Expansion to Include Remicade, Inflectra, and Renflexis
Program effective Date: Nov 01, 2021
Provider
P68-21 eviCore Healthcare Specialty Utilization Management (UM) Program - Laboratory Management Clinical Guideline Updates for Fully Insured Commercial and Medicare Advantage Subscribers
Program effective Date: Nov 01, 2021
Provider
Elagolix/Relugolix - Commercial
Prior Authorization, Quantity Limit
Program effective Date: Apr 01, 2025
Provider
Interleukin-1 (IL-1) Inhibitors - Medicaid
Prior Authorization, Quantity Limit
Program effective Date: Aug 01, 2024